Safety Profile and Lack of Immunogenicity of IncobotulinumtoxinA in Pediatric Spasticity and Sialorrhea: A Pooled Analysis

IncobotulinumtoxinA, a pure botulinumtoxinA formulation, is free of accessory proteins. This analysis provides pooled safety data from phase 3 trials of children/adolescents (2–17 years), investigating incobotulinumtoxinA for the treatment of spasticity associated with cerebral palsy (at doses ≤20 U...

Descripción completa

Detalles Bibliográficos
Autores principales: Berweck, Steffen, Banach, Marta, Gaebler-Spira, Deborah, Chambers, Henry G., Schroeder, A. S., Geister, Thorin L., Althaus, Michael, Hanschmann, Angelika, Vacchelli, Matteo, Bonfert, Michaela V., Heinen, Florian, Dabrowski, Edward
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9505819/
https://www.ncbi.nlm.nih.gov/pubmed/36136523
http://dx.doi.org/10.3390/toxins14090585

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9505819/
https://www.ncbi.nlm.nih.gov/pubmed/36136523
http://dx.doi.org/10.3390/toxins14090585

Ejemplares similares